Denosumab versus zoledronic acid for preventing symptomatic skeletal events in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer: an outcome analyses with a mean follow-up of 3 years

BACKGROUND: The purpose of this study was to evaluate the efficacy of denosumab or zoledronic acid (ZA) using symptomatic skeletal events (SSEs) as the primary endpoint in Asian postmenopausal women with oestrogen-receptor-positive advanced breast cancer. METHODS: Asian postmenopausal women with oes...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chi, Zhang, Fan, Liang, Guanzhao, Zeng, Xianshang, Yu, Weiguang, Jiang, Zhidao, Ma, Jie, Zhao, Mingdong, Xiong, Min, Gui, Keke, Yuan, Fenglai, Ji, Weiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267057/
https://www.ncbi.nlm.nih.gov/pubmed/30497434
http://dx.doi.org/10.1186/s12891-018-2338-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267057/
https://www.ncbi.nlm.nih.gov/pubmed/30497434
http://dx.doi.org/10.1186/s12891-018-2338-6

Ejemplares similares